Skip to main content
Erschienen in: Clinical Rheumatology 11/2009

01.11.2009 | Original Article

Study on clinical features and complications with systemic lupus erythematosus (SLE) activity in Chinese Han population

verfasst von: Lian Hong Li, Hai Feng Pan, Wen Xian Li, Xiang Pei Li, Jian Hua Xu, Dong Qing Ye

Erschienen in: Clinical Rheumatology | Ausgabe 11/2009

Einloggen, um Zugang zu erhalten

Abstract

Systemic lupus erythematosus (SLE) is a complex autoimmune disease affecting multiple organs/systems with variable activities. We performed a retrospective study to investigate the relationship of clinical characteristics and complications with SLE activity in Chinese Han population. A cohort of 1,490 SLE inpatients was evaluated for disease activity using the systemic lupus erythematosus disease activity index (SLEDAI). Chi-square test or Fisher’s exact test was used to compare differences of clinical and laboratory features between active and inactive SLE patients. Logistic regression was chosen to explore the pattern of risk factors for disease activity. We found that neuropsychiatric involvement, nephritis, arthralgia, anti-dsDNA, serositis, hypocomplementemia, oral ulcerations, erythrocyte sedimentation rate, low C3, hematological abnormalities, and systolic pressure (1.010 < odds ratio < 10.568, 1.002 < 95% confidence interval < 31.599, 0.000 < P < 0.026) were major factors associated with disease activity, but not headaches, anti-ribonucleoprotein or anti-Sm, C-reactive protein, and anemia (P > 0.05, respectively). The involvements of urinary system, respiratory system, and central nervous system were significantly more frequent in active SLE than inactive SLE (0.000 < P < 0.014), except for alimentary system (P = 0.399). Our study has comprehensively evaluated the relationship of clinical characteristics and organs/systems involvement of SLE with SLEDAI in Chinese Han population and presented a compendium of factors affecting SLE, which should be useful for better evaluating disease activity and predicting organs/systems damage in SLE for clinical assessments and managements.
Literatur
1.
Zurück zum Zitat Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640PubMedCrossRef Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640PubMedCrossRef
2.
Zurück zum Zitat Uribe AG, Vila LM, McGwin G Jr, Sanchez ML, Reveille JD, Alarcon GS (2004) The systemic lupus activity measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. J Rheumatol 31:1934–1940PubMed Uribe AG, Vila LM, McGwin G Jr, Sanchez ML, Reveille JD, Alarcon GS (2004) The systemic lupus activity measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. J Rheumatol 31:1934–1940PubMed
3.
Zurück zum Zitat Jacobi AM, Rohde W, Ventz M, Riemekasten G, Burmester GR, Hiepe F (2001) Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity. Lupus 10:554–561PubMedCrossRef Jacobi AM, Rohde W, Ventz M, Riemekasten G, Burmester GR, Hiepe F (2001) Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity. Lupus 10:554–561PubMedCrossRef
4.
Zurück zum Zitat Prasad R, Ibanez D, Gladman D, Urowitz M (2006) Anti-dsDNA and anti-Sm antibodies do not predict damage in systemic lupus erythematosus. Lupus 15:285–291PubMedCrossRef Prasad R, Ibanez D, Gladman D, Urowitz M (2006) Anti-dsDNA and anti-Sm antibodies do not predict damage in systemic lupus erythematosus. Lupus 15:285–291PubMedCrossRef
5.
Zurück zum Zitat Ramos-Casals M, Campoamor MT, Chamorro A, Salvador G, Segura S, Botero JC, Yague J, Cervera R, Ingelmo M, Font J (2004) Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients. Lupus 13:777–783PubMedCrossRef Ramos-Casals M, Campoamor MT, Chamorro A, Salvador G, Segura S, Botero JC, Yague J, Cervera R, Ingelmo M, Font J (2004) Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients. Lupus 13:777–783PubMedCrossRef
6.
Zurück zum Zitat Reveille JD (2004) Predictive value of autoantibodies for activity of systemic lupus erythematosus. Lupus 13:290–297PubMedCrossRef Reveille JD (2004) Predictive value of autoantibodies for activity of systemic lupus erythematosus. Lupus 13:290–297PubMedCrossRef
7.
Zurück zum Zitat Yee CS, Hussein H, Skan J, Bowman S, Situnayake D, Gordon C (2003) Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus. Rheumatology (Oxford) 42:276–279CrossRef Yee CS, Hussein H, Skan J, Bowman S, Situnayake D, Gordon C (2003) Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus. Rheumatology (Oxford) 42:276–279CrossRef
8.
Zurück zum Zitat Bertoli AM, Vila LM, Apte M, Fessler BJ, Bastian HM, Reveille JD, Alarcon GS (2007) Systemic lupus erythematosus in a multiethnic US cohort LUMINA LI: anaemia as a predictor of disease activity and damage accrual. Rheumatology (Oxford) 46:1471–1476CrossRef Bertoli AM, Vila LM, Apte M, Fessler BJ, Bastian HM, Reveille JD, Alarcon GS (2007) Systemic lupus erythematosus in a multiethnic US cohort LUMINA LI: anaemia as a predictor of disease activity and damage accrual. Rheumatology (Oxford) 46:1471–1476CrossRef
9.
Zurück zum Zitat Vila LM, Alarcon GS, McGwin G Jr, Bastian HM, Fessler BJ, Reveille JD (2005) Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual. J Rheumatol 32:2150–2155PubMed Vila LM, Alarcon GS, McGwin G Jr, Bastian HM, Fessler BJ, Reveille JD (2005) Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual. J Rheumatol 32:2150–2155PubMed
10.
Zurück zum Zitat Vila LM, Alarcon GS, McGwin G Jr, Bastian HM, Fessler BJ, Reveille JD (2006) Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual. Arthritis Rheum 55:799–806PubMedCrossRef Vila LM, Alarcon GS, McGwin G Jr, Bastian HM, Fessler BJ, Reveille JD (2006) Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual. Arthritis Rheum 55:799–806PubMedCrossRef
11.
Zurück zum Zitat Bertoli AM, Vila LM, Reveille JD, Alarcon GS (2008) Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): LXI. Value of C-reactive protein as a marker of disease activity and damage. J Rheumatol 35:2355–2358PubMedCrossRef Bertoli AM, Vila LM, Reveille JD, Alarcon GS (2008) Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): LXI. Value of C-reactive protein as a marker of disease activity and damage. J Rheumatol 35:2355–2358PubMedCrossRef
12.
Zurück zum Zitat Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725PubMedCrossRef Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725PubMedCrossRef
13.
Zurück zum Zitat Hayakawa I, Hasegawa M, Matsushita T, Yanaba K, Kodera M, Komura K, Takehara K, Sato S (2005) Increased cutaneous T-cell-attracting chemokine levels in sera from patients with systemic sclerosis. Rheumatology (Oxford) 44:873–878CrossRef Hayakawa I, Hasegawa M, Matsushita T, Yanaba K, Kodera M, Komura K, Takehara K, Sato S (2005) Increased cutaneous T-cell-attracting chemokine levels in sera from patients with systemic sclerosis. Rheumatology (Oxford) 44:873–878CrossRef
14.
Zurück zum Zitat Wu O, Liu HH, Li WX, Zhang N, Wang Q, Li XP, Dong MX, Zhang XJ, Ye DQ (2008) Serum soluble nucleosome and the broad family of antinucleosome antibodies are associated with organ and tissue damage in systemic lupus erythematosus in a Chinese population. Clin Exp Dermatol 33:160–163PubMedCrossRef Wu O, Liu HH, Li WX, Zhang N, Wang Q, Li XP, Dong MX, Zhang XJ, Ye DQ (2008) Serum soluble nucleosome and the broad family of antinucleosome antibodies are associated with organ and tissue damage in systemic lupus erythematosus in a Chinese population. Clin Exp Dermatol 33:160–163PubMedCrossRef
15.
Zurück zum Zitat Petri M, Genovese M, Engle E, Hochberg M (1991) Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis Rheum 34:937–944PubMedCrossRef Petri M, Genovese M, Engle E, Hochberg M (1991) Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis Rheum 34:937–944PubMedCrossRef
16.
Zurück zum Zitat Urowitz MB, Gladman DD, Farewell VT, Stewart J, McDonald J (1993) Lupus and pregnancy studies. Arthritis Rheum 36:1392–1397PubMedCrossRef Urowitz MB, Gladman DD, Farewell VT, Stewart J, McDonald J (1993) Lupus and pregnancy studies. Arthritis Rheum 36:1392–1397PubMedCrossRef
17.
Zurück zum Zitat Egner W (2000) The use of laboratory tests in the diagnosis of SLE. J Clin Pathol 53:424–432PubMedCrossRef Egner W (2000) The use of laboratory tests in the diagnosis of SLE. J Clin Pathol 53:424–432PubMedCrossRef
18.
Zurück zum Zitat Spronk PE, Limburg PC, Kallenberg CG (1995) Serological markers of disease activity in systemic lupus erythematosus. Lupus 4:86–94PubMedCrossRef Spronk PE, Limburg PC, Kallenberg CG (1995) Serological markers of disease activity in systemic lupus erythematosus. Lupus 4:86–94PubMedCrossRef
19.
Zurück zum Zitat Boey ML, Peebles CL, Tsay G, Feng PH, Tan EM (1988) Clinical and autoantibody correlations in Orientals with systemic lupus erythematosus. Ann Rheum Dis 47:918–923PubMedCrossRef Boey ML, Peebles CL, Tsay G, Feng PH, Tan EM (1988) Clinical and autoantibody correlations in Orientals with systemic lupus erythematosus. Ann Rheum Dis 47:918–923PubMedCrossRef
20.
Zurück zum Zitat Hoet RM, Koornneef I, de Rooij DJ, van de Putte LB, van Venrooij WJ (1992) Changes in anti-U1 RNA antibody levels correlate with disease activity in patients with systemic lupus erythematosus overlap syndrome. Arthritis Rheum 35:1202–1210PubMedCrossRef Hoet RM, Koornneef I, de Rooij DJ, van de Putte LB, van Venrooij WJ (1992) Changes in anti-U1 RNA antibody levels correlate with disease activity in patients with systemic lupus erythematosus overlap syndrome. Arthritis Rheum 35:1202–1210PubMedCrossRef
21.
Zurück zum Zitat Satoh M, Yamagata H, Watanabe F, Nakayama S, Ogasawara T, Tojo T, Akizuki M (1995) Development of anti-Sm and anti-DNA antibodies followed by clinical manifestation of systemic lupus erythematosus in an elderly woman with long-standing Sjogren’s syndrome. Lupus 4:63–65PubMedCrossRef Satoh M, Yamagata H, Watanabe F, Nakayama S, Ogasawara T, Tojo T, Akizuki M (1995) Development of anti-Sm and anti-DNA antibodies followed by clinical manifestation of systemic lupus erythematosus in an elderly woman with long-standing Sjogren’s syndrome. Lupus 4:63–65PubMedCrossRef
22.
Zurück zum Zitat Yasuma M, Takasaki Y, Matsumoto K, Kodama A, Hashimoto H, Hirose S (1990) Clinical significance of IgG anti-Sm antibodies in patients with systemic lupus erythematosus. J Rheumatol 17:469–475PubMed Yasuma M, Takasaki Y, Matsumoto K, Kodama A, Hashimoto H, Hirose S (1990) Clinical significance of IgG anti-Sm antibodies in patients with systemic lupus erythematosus. J Rheumatol 17:469–475PubMed
23.
Zurück zum Zitat Kurien BT, Scofield RH (2006) Autoantibody determination in the diagnosis of systemic lupus erythematosus. Scand J Immunol 64:227–235PubMedCrossRef Kurien BT, Scofield RH (2006) Autoantibody determination in the diagnosis of systemic lupus erythematosus. Scand J Immunol 64:227–235PubMedCrossRef
24.
Zurück zum Zitat Brunner HI, Jones OY, Lovell DJ, Johnson AM, Alexander P, Klein-Gitelman MS (2003) Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage. Lupus 12:600–606PubMedCrossRef Brunner HI, Jones OY, Lovell DJ, Johnson AM, Alexander P, Klein-Gitelman MS (2003) Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage. Lupus 12:600–606PubMedCrossRef
25.
Zurück zum Zitat Alarcon GS, McGwin G Jr, Bastian HM, Roseman J, Lisse J, Fessler BJ, Friedman AW, Reveille JD (2001) Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum 45:191–202PubMedCrossRef Alarcon GS, McGwin G Jr, Bastian HM, Roseman J, Lisse J, Fessler BJ, Friedman AW, Reveille JD (2001) Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum 45:191–202PubMedCrossRef
26.
Zurück zum Zitat Chen YE, Korbet SM, Katz RS, Schwartz MM, Lewis EJ (2008) Value of a complete or partial remission in severe lupus nephritis. Clin J Am Soc Nephrol 3:46–53PubMedCrossRef Chen YE, Korbet SM, Katz RS, Schwartz MM, Lewis EJ (2008) Value of a complete or partial remission in severe lupus nephritis. Clin J Am Soc Nephrol 3:46–53PubMedCrossRef
27.
Zurück zum Zitat Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD (2000) Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis 35:904–914PubMedCrossRef Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD (2000) Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis 35:904–914PubMedCrossRef
28.
Zurück zum Zitat Duran-Barragan S, Ruvalcaba-Naranjo H, Rodriguez-Gutierrez L, Solano-Moreno H, Hernandez-Rios G, Sanchez-Ortiz A, Ramos-Remus C (2008) Recurrent urinary tract infections and bladder dysfunction in systemic lupus erythematosus. Lupus 17:1117–1121PubMedCrossRef Duran-Barragan S, Ruvalcaba-Naranjo H, Rodriguez-Gutierrez L, Solano-Moreno H, Hernandez-Rios G, Sanchez-Ortiz A, Ramos-Remus C (2008) Recurrent urinary tract infections and bladder dysfunction in systemic lupus erythematosus. Lupus 17:1117–1121PubMedCrossRef
29.
30.
Zurück zum Zitat Sitia S, Atzeni F, Sarzi-Puttini P, Di Bello V, Tomasoni L, Delfino L, Antonini-Canterin F, Di Salvo G, De Gennaro Colonna V, La Carrubba S et al (2009) Cardiovascular involvement in systemic autoimmune diseases. Autoimmun Rev 8:281–286PubMedCrossRef Sitia S, Atzeni F, Sarzi-Puttini P, Di Bello V, Tomasoni L, Delfino L, Antonini-Canterin F, Di Salvo G, De Gennaro Colonna V, La Carrubba S et al (2009) Cardiovascular involvement in systemic autoimmune diseases. Autoimmun Rev 8:281–286PubMedCrossRef
31.
Zurück zum Zitat FitzGerald JD, Grossman JM (1999) Validity and reliability of retrospective assessment of disease activity and flare in observational cohorts of lupus patients. Lupus 8:638–644PubMedCrossRef FitzGerald JD, Grossman JM (1999) Validity and reliability of retrospective assessment of disease activity and flare in observational cohorts of lupus patients. Lupus 8:638–644PubMedCrossRef
32.
Zurück zum Zitat Thumboo J, Lee HY, Fong KY, Chan SP, Chapman CA, Leong KH, Feng PH, Thio ST, Boey ML (2000) Accuracy of medical record scoring of the SLICC/ACR damage index for systemic lupus erythematosus. Lupus 9:358–362PubMedCrossRef Thumboo J, Lee HY, Fong KY, Chan SP, Chapman CA, Leong KH, Feng PH, Thio ST, Boey ML (2000) Accuracy of medical record scoring of the SLICC/ACR damage index for systemic lupus erythematosus. Lupus 9:358–362PubMedCrossRef
Metadaten
Titel
Study on clinical features and complications with systemic lupus erythematosus (SLE) activity in Chinese Han population
verfasst von
Lian Hong Li
Hai Feng Pan
Wen Xian Li
Xiang Pei Li
Jian Hua Xu
Dong Qing Ye
Publikationsdatum
01.11.2009
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 11/2009
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-009-1240-x

Weitere Artikel der Ausgabe 11/2009

Clinical Rheumatology 11/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.